Caribou Biosciences, Inc. (CRBU)
1.305
0.00 (0.00%)
USD |
NASDAQ |
Sep 21, 16:00
1.305
0.00 (0.00%)
After-Hours: 20:00
Caribou Biosciences Market Cap : 138.32M for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 137.79M |
| September 17, 2026 | 138.85M |
| September 16, 2026 | 132.49M |
| September 15, 2026 | 134.61M |
| September 14, 2026 | 136.73M |
| September 11, 2026 | 134.61M |
| September 10, 2026 | 145.21M |
| September 09, 2026 | 152.63M |
| September 08, 2026 | 163.23M |
| September 04, 2026 | 166.41M |
| September 03, 2026 | 166.41M |
| September 02, 2026 | 169.59M |
| September 01, 2026 | 164.29M |
| August 31, 2026 | 163.23M |
| August 28, 2026 | 171.71M |
| August 27, 2026 | 175.95M |
| August 26, 2026 | 174.89M |
| August 25, 2026 | 186.55M |
| August 24, 2026 | 173.83M |
| August 21, 2026 | 175.95M |
| August 20, 2026 | 170.65M |
| August 19, 2026 | 173.83M |
| August 18, 2026 | 165.35M |
| August 17, 2026 | 166.41M |
| August 14, 2026 | 167.47M |
| Date | Value |
|---|---|
| August 13, 2026 | 170.65M |
| August 12, 2026 | 180.19M |
| August 11, 2026 | 179.13M |
| August 10, 2026 | 160.94M |
| August 07, 2026 | 159.97M |
| August 06, 2026 | 159.00M |
| August 05, 2026 | 156.09M |
| August 04, 2026 | 152.21M |
| August 03, 2026 | 145.43M |
| July 31, 2026 | 141.55M |
| July 30, 2026 | 146.40M |
| July 29, 2026 | 142.52M |
| July 28, 2026 | 144.46M |
| July 27, 2026 | 154.15M |
| July 24, 2026 | 152.21M |
| July 23, 2026 | 158.03M |
| July 22, 2026 | 160.94M |
| July 21, 2026 | 159.97M |
| July 20, 2026 | 157.06M |
| July 17, 2026 | 159.97M |
| July 16, 2026 | 160.94M |
| July 15, 2026 | 167.73M |
| July 14, 2026 | 169.66M |
| July 13, 2026 | 174.51M |
| July 10, 2026 | 186.63M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Intellia Therapeutics, Inc. | 1.712B |
| Vir Biotechnology, Inc. | 1.840B |
| Arrowhead Pharmaceuticals, Inc. | 9.710B |
| Oncolytics Biotech, Inc. | 95.71M |
| Sangamo Therapeutics, Inc. | 60.03M |
Market Cap Related Metrics
| PS Ratio | 12.51 |
| Price to Book Value | 1.410 |
| Price | 1.305 |
| Earnings Yield | -82.57% |